ESMO Clinical Practice Guideline interim update on the use of targeted therapy in acute lymphoblastic leukaemia
(2023) In Annals of Oncology
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/40d59a81-720d-4fed-a489-dfe99cb951ae
- author
- Hoelzer, D. ; Bassan, R. ; Boissel, N. ; Roddie, C. ; Ribera, J. M. and Jerkeman, M. LU
- author collaboration
- organization
- publishing date
- 2023
- type
- Contribution to journal
- publication status
- in press
- subject
- keywords
- acute lymphoblastic leukaemia, ESMO Clinical Practice Guideline update, immunotherapy, treatment, tyrosine kinase inhibitor
- in
- Annals of Oncology
- publisher
- Oxford University Press
- external identifiers
-
- pmid:37832649
- scopus:85180598764
- ISSN
- 0923-7534
- DOI
- 10.1016/j.annonc.2023.09.3112
- language
- English
- LU publication?
- yes
- id
- 40d59a81-720d-4fed-a489-dfe99cb951ae
- date added to LUP
- 2024-02-07 15:38:45
- date last changed
- 2024-04-23 22:29:40
@article{40d59a81-720d-4fed-a489-dfe99cb951ae, author = {{Hoelzer, D. and Bassan, R. and Boissel, N. and Roddie, C. and Ribera, J. M. and Jerkeman, M.}}, issn = {{0923-7534}}, keywords = {{acute lymphoblastic leukaemia; ESMO Clinical Practice Guideline update; immunotherapy; treatment; tyrosine kinase inhibitor}}, language = {{eng}}, publisher = {{Oxford University Press}}, series = {{Annals of Oncology}}, title = {{ESMO Clinical Practice Guideline interim update on the use of targeted therapy in acute lymphoblastic leukaemia}}, url = {{http://dx.doi.org/10.1016/j.annonc.2023.09.3112}}, doi = {{10.1016/j.annonc.2023.09.3112}}, year = {{2023}}, }